MoonLake Immunotherapeutics (MLTX)
10.09
-0.68
(-6.31%)
USD |
NASDAQ |
Oct 08, 14:05
MoonLake Immunotherapeutics Total Assets (Quarterly) : 573.95M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 573.95M |
| March 31, 2026 | 400.37M |
| December 31, 2025 | 424.43M |
| September 30, 2025 | 414.34M |
| June 30, 2025 | 460.10M |
| March 31, 2025 | 511.26M |
| December 31, 2024 | 477.93M |
| September 30, 2024 | 518.21M |
| June 30, 2024 | 544.88M |
| March 31, 2024 | 564.12M |
| December 31, 2023 | 526.54M |
| September 30, 2023 | 500.22M |
| Date | Value |
|---|---|
| June 30, 2023 | 506.62M |
| March 31, 2023 | 66.80M |
| December 31, 2022 | 76.84M |
| September 30, 2022 | 88.59M |
| June 30, 2022 | 98.43M |
| March 31, 2022 | 231.21M |
| December 31, 2021 | 9.682M |
| September 30, 2021 | 116.25M |
| June 30, 2021 | 116.37M |
| March 31, 2021 | 116.49M |
| December 31, 2020 | 116.63M |
| September 30, 2020 | 0.1635M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 9.176B |
| AC Immune SA | 186.45M |
| CRISPR Therapeutics AG | 2.651B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 145.75M |
| Shareholders Equity (Quarterly) | 428.20M |
| Debt to Equity Ratio | 0.2371 |
| Current Ratio | 12.56 |
| Net Debt Paydown Yield | -0.32% |